Deep Track Capital as of Sept. 30, 2024
Portfolio Holdings for Deep Track Capital
Deep Track Capital holds 69 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Argenx Se Sponsored Adr (ARGX) | 6.3 | $198M | 365k | 542.08 | |
| Dynavax Technologies Corp Com New (DVAX) | 4.4 | $140M | 13M | 11.14 | |
| Guardant Health (GH) | 4.4 | $138M | 6.0M | 22.94 | |
| Apellis Pharmaceuticals (APLS) | 4.0 | $127M | 4.4M | 28.84 | |
| Immunovant (IMVT) | 3.9 | $124M | 4.3M | 28.51 | |
| Springworks Therapeutics (SWTX) | 3.9 | $123M | 3.8M | 32.04 | |
| Dyne Therapeutics (DYN) | 3.7 | $118M | 3.3M | 35.92 | |
| Intra Cellular Therapies (ITCI) | 3.7 | $117M | 1.6M | 73.17 | |
| Ocular Therapeutix (OCUL) | 3.5 | $111M | 13M | 8.70 | |
| Intellia Therapeutics (NTLA) | 3.2 | $102M | 5.0M | 20.55 | |
| Alkermes SHS (ALKS) | 3.1 | $98M | 3.5M | 27.99 | |
| Axsome Therapeutics Call Option (AXSM) | 3.0 | $95M | 1.1M | 89.87 | |
| Verona Pharma Sponsored Ads (VRNA) | 2.9 | $92M | 3.2M | 28.77 | |
| Ionis Pharmaceuticals (IONS) | 2.8 | $88M | 2.2M | 40.06 | |
| Nurix Therapeutics (NRIX) | 2.8 | $87M | 3.9M | 22.47 | |
| Miragen Therapeutics (VRDN) | 2.7 | $85M | 3.8M | 22.75 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 2.5 | $80M | 3.5M | 22.63 | |
| Mbx Biosciences (MBX) | 2.5 | $78M | 3.0M | 25.98 | |
| Pliant Therapeutics (PLRX) | 2.1 | $67M | 6.0M | 11.21 | |
| Apogee Therapeutics (APGE) | 1.9 | $59M | 1.0M | 58.74 | |
| Autolus Therapeutics Spon Ads (AUTL) | 1.8 | $55M | 15M | 3.63 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 1.7 | $54M | 1.2M | 43.89 | |
| Olema Pharmaceuticals (OLMA) | 1.5 | $48M | 4.0M | 11.94 | |
| Terns Pharmaceuticals (TERN) | 1.5 | $47M | 5.6M | 8.34 | |
| 4d Molecular Therapeutics In (FDMT) | 1.4 | $44M | 4.1M | 10.81 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.3 | $41M | 3.6M | 11.52 | |
| Tg Therapeutics (TGTX) | 1.3 | $40M | 1.7M | 23.39 | |
| Mind Medicine Mindmed Com New (MNMD) | 1.3 | $40M | 7.1M | 5.69 | |
| Kura Oncology (KURA) | 1.2 | $38M | 2.0M | 19.54 | |
| Geron Corporation (GERN) | 1.1 | $34M | 7.6M | 4.54 | |
| Cytokinetics Com New (CYTK) | 1.1 | $33M | 630k | 52.80 | |
| Oruka Therapeutics (ORKA) | 1.0 | $30M | 1.2M | 24.51 | |
| Biosante Pharmaceuticals (ANIP) | 1.0 | $30M | 505k | 59.66 | |
| Spyre Therapeutics Com New (SYRE) | 0.9 | $29M | 1.0M | 29.41 | |
| Edgewise Therapeutics (EWTX) | 0.9 | $29M | 1.1M | 26.69 | |
| Kymera Therapeutics (KYMR) | 0.9 | $28M | 600k | 47.33 | |
| Korro Bio (KRRO) | 0.9 | $28M | 850k | 33.42 | |
| Avidity Biosciences Ord (RNA) | 0.7 | $22M | 475k | 45.93 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.7 | $22M | 1.4M | 15.99 | |
| Alector (ALEC) | 0.7 | $22M | 4.6M | 4.66 | |
| Nektar Therapeutics | 0.7 | $21M | 16M | 1.30 | |
| 89bio (ETNB) | 0.6 | $21M | 2.8M | 7.40 | |
| Bicara Therapeutics (BCAX) | 0.6 | $20M | 797k | 25.47 | |
| Akero Therapeutics (AKRO) | 0.6 | $20M | 690k | 28.69 | |
| Fate Therapeutics (FATE) | 0.6 | $20M | 5.6M | 3.50 | |
| Silence Therapeutics Ads (SLN) | 0.6 | $18M | 1.0M | 18.18 | |
| Engene Holdings (ENGN) | 0.5 | $17M | 2.6M | 6.60 | |
| Editas Medicine (EDIT) | 0.5 | $17M | 4.9M | 3.41 | |
| Xencor (XNCR) | 0.5 | $16M | 800k | 20.11 | |
| Pyxis Oncology Common Stock (PYXS) | 0.5 | $15M | 4.2M | 3.67 | |
| Context Therapeutics (CNTX) | 0.5 | $15M | 7.4M | 1.96 | |
| Cybin Com New (CYBN) | 0.4 | $14M | 1.5M | 8.89 | |
| Zura Bio Class A Ord Shs (ZURA) | 0.4 | $13M | 3.3M | 4.06 | |
| Adagio Therapeutics (IVVD) | 0.4 | $11M | 11M | 1.02 | |
| Eliem Therapeutics (CLYM) | 0.4 | $11M | 2.2M | 5.09 | |
| Inovio Pharmaceuticals Com Shs (INO) | 0.3 | $10M | 1.8M | 5.78 | |
| Neumora Therapeutics Call Option (NMRA) | 0.3 | $9.9M | 748k | 13.21 | |
| Avalo Therapeutics Com New (AVTX) | 0.3 | $9.2M | 967k | 9.50 | |
| Travere Therapeutics (TVTX) | 0.2 | $7.4M | 532k | 13.99 | |
| Vigil Neuroscience (VIGL) | 0.2 | $5.3M | 1.6M | 3.40 | |
| Regulus Therapeutics | 0.2 | $5.1M | 3.3M | 1.57 | |
| Allakos | 0.1 | $3.3M | 5.0M | 0.65 | |
| Alto Neuroscience Com Shs (ANRO) | 0.1 | $2.5M | 220k | 11.44 | |
| Prothena Corp SHS (PRTA) | 0.1 | $2.3M | 140k | 16.73 | |
| Relmada Therapeutics (RLMD) | 0.1 | $2.2M | 675k | 3.24 | |
| Aligos Therapeutics Com New (ALGS) | 0.1 | $2.1M | 244k | 8.66 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.1 | $1.8M | 829k | 2.15 | |
| Metagenomi (MGX) | 0.0 | $667k | 308k | 2.17 | |
| Scholar Rock Hldg Corp (SRRK) | 0.0 | $385k | 48k | 8.01 |
